Monday, 2 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Acquisition

Covidh Technologies Acquisition Worth ₹78 Cr

iSERA Lifesciences Limited approved the acquisition of a 100% stake in iSERA Biological Limited for ₹78 Crore via a 1:1 share swap. The transaction will be executed through a preferential allotment of 1,61,82,800 equity shares at ₹48.20 per share. Upon completion, iSERA Biological will become a wholly-owned subsidiary.

Key figures
Value₹78.00 Cr
Execution periodWithin 15 days of shareholder or BSE approval
Source

BSE filing, NSE: COVIDH. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Covidh Technologies Ltd: key numbers

Share price
₹143.90
Market cap
₹121.0 Cr
Revenue (annual)
₹1.36 Cr
Net profit (annual)
₹0.26 Cr
P/E (TTM)
466.5×Sector 23.5×
Promoter holding
55.07%-3.56% QoQ
FII holding
0.01%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Covidh Technologies Ltd

All →

Other acquisition announcements

All →